Fund BasicsSee More
- Fund Family REX Shares
- Assets Under Management 20,295,000
- Shares Outstanding, K 500
- 60-Month Beta 4.18
- Price/Earnings ttm 3.26
- Annual Dividend & Yield N/A
- Most Recent Dividend N/A
- Management Fee 0.95%
|Period||Period Low||Period High||Performance|
| || |
+13.53 (+49.25%)since 02/03/21
| || |
+19.29 (+88.85%)since 12/03/20
| || |
-0.54 (-1.30%)since 03/03/20
Last week was quite a lull for Wall Street. A jump in U.S. treasury yields can be held responsible for the broader market underperformance.
Solid corporate earnings and expectations of a fat stimulus by U.S. President Joe Biden's administration have renewed the appeal for the riskier assets last week.
The solid fundamentals and a soaring stock market have resulted in huge demand for the leveraged ETFs.
Wall Street spiked on Nov 9 on news that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial.
Wall Street was upbeat last week with the S&P 500, the Dow Jones and the Nasdaq gaining about 3.3%, 2.6% and 3.4%, respectively. These leveraged ETFs were the top-performers last week.
The U.S. stock market extended its bull rally to start the month of June with surprisingly upbeat job data.
The series of developments last week have spurred huge demand for leveraged ETFs as investors seek to register big gains in a shorter span of time.
Inside the best five best leveraged ETFs of November.
We have highlighted a few leveraged equity ETFs that have piled up more than 25% returns so far in the fourth quarter and could continue to be investors' darlings.
We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.
|3rd Resistance Point||42.87|
|2nd Resistance Point||42.30|
|1st Resistance Point||41.45|
|1st Support Level||40.03|
|2nd Support Level||39.46|
|3rd Support Level||38.61|